This study provides the experimental evidence for the protective role of FBXW7 against innate immune dysfunction-mediated NAFLD development, as well as the mechanism underlying this action, indicating that FBXW7 is a potential target for therapeutic intervention in NAFLD. Here, FBXW7 is linked to metabolic dysfunction-associated steatotic liver disease.